Shares Of Pandora Media (P) Turn Most Active Than Frontier Communications (FTR), Galena Biopharma (GALE), Staples (SPLS)

Apple Inc. (AAPL) is in advanced meeting to purchase high-end headphone maker and music-streaming service Beats Electronics LLC for $3.2 billion, according to media declares on Thursday. A deal, which could be reported as early as next week, would enable Apple to strengthen its music business. Santa Monica, California-based Beats Electronics, co-founded by music industry executive Jimmy Iovine and hip-hop artist Dr. Pandora Media, Inc. (P), Broadcasting – Radio, is currently trading at $27.04, which surged 2.04%. The stock is trading -19.76% below its 50 days high and 25.94% above its 50 days low. At the closing bell, shares in Pandora Media, Inc. recorded a trading volume of 7275390. Its total outstanding shares are 205.45 million with the market capitalization of $5555.37 million. P showed 5.71% weekly performance. Analysts rate it a ‘Hold’ stock.

Frontier Communications Corporation (FTR) Tuesday announced first-quarter profit of $39.3 million or $0.04 per share, down from $48.1 million or $0.05 per share in the same period last year. Adjusted earnings for the quarter were $48.4 million or $0.05 per share. On average, 11 analysts polled by Thomson Reuters potential the company to earn $0.07 per share for the quarter. Frontier Communications Corporation (FTR), Telecom Services – Domestic company, gained 1.08% in last trading session and ended the day on $5.64. The stock is trading -5.95% below its 52-week high and 61.14% above its 52-week low. FTR has $5652.92 million market capitalization. The stock recorded a trading volume of 7205671 shares as compared to its average volume of 11838.93 million shares. FTR’s year to date performance is 25.89%. Experts rate it a ‘Hold’ stock.

Aegerion Pharmaceuticals Inc. (AEGR) slipped further than 16 percent to $36.80 in later-hours on Tuesday as it lowered its net product sales guidance for 2014 due to accrue order delays in Brazil, the company’s number two revenue-generating country. Accordingly, Aegerion now expects global net product sales of between $180 million and $200 million for FY 2014, revised from the prior range of between $190 million and $210 million. In the first-quarter ended March 31, 2014, non-GAAP net loss, which excludes stock-based compensation, narrowed to $7.3 million or $0.25 per share on net product sales of $27.0 million. The price of Galena Biopharma, Inc. (GALE), Biotechnology company, stock fell -6.77% to $2.89. The stock is dealing at -62.81% below its 52-week high and 75.15% above its 52-week low. Company has 118.01 million shares outstanding with $341.05 million market capitalization. Galena Biopharma, Inc. has -$0.69 EPS currently and sees -60.40% growth this year and 3.30% next year. GALE’s yearly performance is 38.28%. We recommend to ‘Hold’ the stock.

Staples Inc. (SPLS) declared first quarter adjusted EPS of $0.18 Tuesday morning, which shrunk short of the consensus estimate of $0.21. Looking ahead to the second quarter, the company expects adjusted EPS of $0.09 to $0.14. Analysts are expecting EPS of $0.15. Staples gapped open sharply lower Tuesday and slipped additional during the second half of the morning. Staples, Inc. (SPLS), Specialty Retail, Other company, crashed -0.99% in last trading session and ended the day on $10.99. The stock is trading -34.80% below its 52-week high and 1.20% above its 52-week low. SPLS’s payout ratio is 56.50% with dividend yield of 4.37%. EPS growth over next 5 years is estimated to be -1.18% and 545.80% in this year. The current ratio was 1.60 times. SPLS’s yearly performance is -27.55%. Trade experts think of it as ‘Moderate Sell’ stock.

About

Elizabeth Clark, CPA, is a senior analyst for The Downtown Leader. If you have a great story idea for Elizabeth Clark, you can write at [Elizabeth.Clark@downtownleader.com ].

POST YOUR COMMENTS